A Study of Second-line Treatment With Apatinib for Advanced Intrahepatic Cholangiocarcinoma
Clinical trial NCT03521219 · UNKNOWN
Trial details
- NCT number
- NCT03521219
- Sponsor
- The First Affiliated Hospital of Zhengzhou University
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-02-07
- Primary completion
- 2018-11-01
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.